# Analysis and Evaluation of Smoking Treatment With Cytisine

> **NCT06439303** · — · RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 65 (estimated)

## Conditions studied

- Moderate or Severe Tobacco Use Disorder

## Interventions

- **DRUG:** Cytisine 1,5 mg

## Key facts

- **NCT ID:** NCT06439303
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-20
- **Primary completion:** 2024-06-20
- **Final completion:** 2024-06-20
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06439303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06439303, "Analysis and Evaluation of Smoking Treatment With Cytisine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06439303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*